➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Express Scripts
Baxter
Dow
McKinsey

Last Updated: September 16, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMINOSALICYLIC ACID RESIN COMPLEX

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Aminosalicylic Acid Resin Complex

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000796 ↗ A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRT Completed National Institute of Allergy and Infectious Diseases (NIAID) N/A 1969-12-31 To determine the demographic, behavioral, clinical, and geographic risk factors associated with the occurrence of multidrug-resistant pulmonary tuberculosis (MDRTB). To evaluate the clinical and microbiological responses and overall survival of MDRTB patients who are treated with levofloxacin-containing multiple-drug regimens chosen from a hierarchical list. Per 9/28/94 amendment, to assess whether persistent or recurrent positive sputum cultures of patients who show failure or relapse are due to the same strain or reinfection with a new strain. Among TB patients, there has been an increase in progressive disease due to the emergence of antimycobacterial drug-resistant strains of Mycobacterium tuberculosis. Failure to identify patients at high risk for MDRTB increases the hazard for both treatment failure and development of resistance to additional therapeutic agents. Efforts to improve survival in patients with MDRTB will depend on improved methods of assessing the risk of acquisition of MDRTB and identifying drug susceptibility patterns in a timely fashion.
NCT00004288 ↗ Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis Completed University of Rochester Phase 2 1996-05-01 OBJECTIVES: I. Assess the safety and efficacy of olsalazine, a dimer of 5-aminosalicylic acid, in men with ankylosing spondylitis unresponsive to nonsteroidal anti-inflammatory drugs and physiotherapy.
NCT00004288 ↗ Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis Completed National Center for Research Resources (NCRR) Phase 2 1996-05-01 OBJECTIVES: I. Assess the safety and efficacy of olsalazine, a dimer of 5-aminosalicylic acid, in men with ankylosing spondylitis unresponsive to nonsteroidal anti-inflammatory drugs and physiotherapy.
NCT00004423 ↗ Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease Completed University of Vermont N/A 1995-12-01 OBJECTIVES: I. Assess the efficacy and safety of 4-aminosalicylic acid in patients with active Crohn's disease of the small bowel.
NCT00004810 ↗ Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis Completed University of Vermont Phase 2 1996-06-01 OBJECTIVES: I. Assess the safety and efficacy of 4-aminosalicylic acid in patients with mildly to moderately severe ulcerative colitis.
NCT00004810 ↗ Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis Completed National Center for Research Resources (NCRR) Phase 2 1996-06-01 OBJECTIVES: I. Assess the safety and efficacy of 4-aminosalicylic acid in patients with mildly to moderately severe ulcerative colitis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Aminosalicylic Acid Resin Complex

Condition Name

Condition Name for Aminosalicylic Acid Resin Complex
Intervention Trials
Ulcerative Colitis 9
Crohn's Disease 5
Colitis, Ulcerative 4
HIV Infections 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Aminosalicylic Acid Resin Complex
Intervention Trials
Colitis, Ulcerative 14
Ulcer 13
Colitis 13
Crohn Disease 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Aminosalicylic Acid Resin Complex

Trials by Country

Trials by Country for Aminosalicylic Acid Resin Complex
Location Trials
United States 38
Canada 5
Israel 5
Japan 4
Korea, Republic of 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Aminosalicylic Acid Resin Complex
Location Trials
California 4
New York 4
Texas 3
Illinois 3
Utah 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Aminosalicylic Acid Resin Complex

Clinical Trial Phase

Clinical Trial Phase for Aminosalicylic Acid Resin Complex
Clinical Trial Phase Trials
Phase 4 3
Phase 3 4
Phase 2/Phase 3 2
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Aminosalicylic Acid Resin Complex
Clinical Trial Phase Trials
Completed 12
Terminated 6
Recruiting 5
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Aminosalicylic Acid Resin Complex

Sponsor Name

Sponsor Name for Aminosalicylic Acid Resin Complex
Sponsor Trials
Otsuka Pharmaceutical Co., Ltd. 4
Jacobus Pharmaceutical 2
University of Vermont 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Aminosalicylic Acid Resin Complex
Sponsor Trials
Other 19
Industry 10
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Baxter
Merck
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.